Q3 2024 13F Holders as of 30 Sep 2024
-
Type / Class
-
Equity / Class A Common Stock, par value $0.0001 per share
-
Shares outstanding
-
126M
-
Number of holders
-
110
-
Total 13F shares, excl. options
-
63.5M
-
Shares change
-
+572K
-
Total reported value, excl. options
-
$182M
-
Value change
-
+$1.72M
-
Number of buys
-
52
-
Number of sells
-
-52
-
Price
-
$2.86
Significant Holders of Organogenesis Holdings Inc. - Class A Common Stock, par value $0.0001 per share (ORGO) as of Q3 2024
128 filings reported holding ORGO - Organogenesis Holdings Inc. - Class A Common Stock, par value $0.0001 per share as of Q3 2024.
Organogenesis Holdings Inc. - Class A Common Stock, par value $0.0001 per share (ORGO) has 110 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 63.5M shares
of 126M outstanding shares and own 50.3% of the company stock.
Largest 10 shareholders include MORGAN STANLEY (12M shares), Soleus Capital Management, L.P. (11.8M shares), BlackRock, Inc. (5.33M shares), DEUTSCHE BANK AG\ (4.84M shares), VANGUARD GROUP INC (3.67M shares), ACADIAN ASSET MANAGEMENT LLC (3.02M shares), AQR CAPITAL MANAGEMENT LLC (2.71M shares), DIMENSIONAL FUND ADVISORS LP (2.35M shares), Assenagon Asset Management S.A. (1.92M shares), and GEODE CAPITAL MANAGEMENT, LLC (1.75M shares).
This table shows the top 110 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.